收藏切换
Visual analysis of treatment status and research hotspots concerning medications treatment for rheumatoid arthritis-associated interstitial lung disease
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(10) : 3626 - 3636
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(10): 3626-3636
Visual analysis of treatment status and research hotspots concerning medications treatment for rheumatoid arthritis-associated interstitial lung disease
Full
ZHAO Qingyu1, HE Lianhua2,3, YAN Qianqian1, LI Xiaoxuan1, WANG Jialin1, LIN Na1, LIU Chunfang1
Affiliations
    1 Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China;
    2 Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, China;
    3 Shenzhen China Resources Sanjiu Medicine Trading Co., Ltd., Shenzhen 518109, China
doi: 10.7501/j.issn.0253-2670.2025.10.020
Outline
收藏切换
Objective To analyze the research status and hotspots concerning medications treatment for rheumatoid arthritis-related interstitial lung disease (RA-ILD) using bibliometric methods. Methods Literature on drug treatments for RA-ILD was retrieved from Web of Science, PubMed, China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases, covering studies up to February 10, 2025. The VOSviewer and CiteSpace software were used to conduct visual analyses on the annual number of literatures, highly cited literatures and journals, national and institutional contributions, author co-occurrence, keyword co-occurrence, keyword timelines, clinical research indicators, basic experimental indicators, and specific drug usage statistics. Results A total of 204 English-language articles and 127 Chinese-language articles were included, showing an overall increasing trend in publication volume. The country with the highest number of English publications was the United States. The institutions with the highest publication output were the University of Modena and Reggio Emilia (Italy) for English articles, and Beijing University of Chinese Medicine (China) for Chinese articles. The journals with the most published articles were Rheumatism and Arthritis and Rheumatology. The most prolific authors were Marco Sebastiani for English articles and Songwei Li for Chinese articles. High-frequency keywords included “mortality, idiopathic pulmonary fibrosis, pneumonia, methotrexate and rituximab” in English literature, and “lung function, pulmonary interstitial fibrosis, interstitial pneumonia, cyclophosphamide and tripterygium glycosides tablet” in Chinese literature. The volume of publications on the treatment of RA-ILD with chemical drugs and biological agents exceeds that of traditional Chinese medicine (TCM). Among chemical drugs, immunosuppressants are the most frequently used. In TCM therapies, drugs for promoting blood circulation, tonifying the lung, spleen, and kidney, and replenishing qi are the most commonly employed. Clinically, pulmonary imaging, pulmonary function tests, and blood parameter detection serve as the primary indicators for evaluating drug efficacy. Basic experimental research in this field is relatively inadequate. In terms of efficacy assessment, lung tissue histological observation and the detection of fibrosis markers are the main indicators. Conclusion Currently, the pharmacological treatment of RA-ILD predominantly relies on chemical drugs and biological agents, with clinical research being the dominant research type. Regarding research hotspots, studies on chemical drugs and biological agents primarily focus on mortality rates and risk factors, with a particular emphasis on drug safety. In contrast, TCM research centers on therapeutic methods and efficacy. Anti-fibrotic chemical drugs and TCM, especially basic research in TCM, are expected to become the future research trends in RA-ILD.
rheumatoid arthritis-associated interstitial lung disease  /  immunosuppressant  /  traditional Chinese medicine  /  antifibrosis  /  CiteSpace  /  VOSviewer
赵清玉, 何莲花, 严倩倩, 李晓萱, 王佳琳, 林娜, 刘春芳. 类风湿关节炎相关间质性肺病药物治疗现状和研究热点的可视化分析. 中草药, 2025 , 56 (10) : 3626 -3636 . DOI: 10.7501/j.issn.0253-2670.2025.10.020
ZHAO Qingyu, HE Lianhua, YAN Qianqian, LI Xiaoxuan, WANG Jialin, LIN Na, LIU Chunfang. Visual analysis of treatment status and research hotspots concerning medications treatment for rheumatoid arthritis-associated interstitial lung disease[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (10) : 3626 -3636 . DOI: 10.7501/j.issn.0253-2670.2025.10.020
Year 2025 volume 56 Issue 10
44
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.10.020
  • Receive Date:2025-02-20
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2025-02-20
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.10.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT